PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-06

Date Title Company
06-Oct-2025 Lilly and Leading Alzheimer’s Disease Experts Call for Urgent Action to Close Diagnostic Gaps at Alzheimer Europe Conference Eli Lilly and Company
06-Oct-2025 President of The Physiological Society congratulates 2025 Nobel Prize winners The Physiological Society
06-Oct-2025 Adva Biotechnology and Autolomous Launch the Digital PIONEER Program to Enable Decentralized, Scalable Cell Therapy Manufacturing — GenCART Inc. Joins as First Clinical Participant Adva Biotechnology Ltd
06-Oct-2025 Celltrion presents positive real-world data on switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions Celltrion inc
06-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Oct-2025 Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study Businesswire
06-Oct-2025 GenesisCare UK appoints Dr Peter Dickinson to lead its Elekta Unity MR Linac programme Genesis Care UK
06-Oct-2025 Revolutionary blood test for ME / Chronic Fatigue unveiled University of East Anglia and Oxford Biodynamics
06-Oct-2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Onco3R Therapeutics
06-Oct-2025 Dubai Marathon Physiotherapy: Your Path to the Finish Line ACCESS Newswire
06-Oct-2025 Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions Businesswire
06-Oct-2025 BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial of ML-016 in Advanced Cancers with Lung and/or Liver Involvement ACCESS Newswire
06-Oct-2025 Medical Care Technologies (OTC PINK:MDCE) Launches Next-Generation AI Validation Program Targeting Clinical-Grade Accuracy ACCESS Newswire
06-Oct-2025 Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline ACCESS Newswire
06-Oct-2025 Alligator Bioscience Announces Acceptance of Two Abstracts at SITC 40th Anniversary Annual Meeting ACCESS Newswire
06-Oct-2025 Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID) ACCESS Newswire
06-Oct-2025 Daytona Beach Clinical Trial Site Now Enrolling for Heart Protection Study ACCESS Newswire
06-Oct-2025 NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform Businesswire
06-Oct-2025 Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System ACCESS Newswire
06-Oct-2025 Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform ACCESS Newswire